Sio Capital Management
Latest statistics and disclosures from Sio Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Quotient Ltd shs, BIIB, CERN, CAH, AMGN. These five stock positions account for 36.36% of Sio Capital Management's total stock portfolio.
- Added to shares of these 10 stocks: BIIB (+$14.75M), CERN (+$13.48M), ATHN (+$10.09M), ABT (+$6.86M), Medtronic (+$6.51M), PFE (+$6.34M), HRC, Tesaro, NVO, ECL.
- Started 19 new stock positions in ABT, ECL, Medtronic, HRC, PFE, Quintiles Transnatio Hldgs I, NVO, BIIB, Sage Therapeutics, Tesaro. CERN, AFAM, Aeglea Biotherapeutics, BMY, CELG, Viking Therapeutics, Tearlab, Aratana Therapeutics, Chemocentryx.
- Reduced shares in these 10 stocks: , MCK (-$13.74M), , LLY (-$10.11M), , , , , , JNJ (-$5.46M).
- Sold out of its positions in Actavis, Agile Therapeutics, ALNY, Biotelemetry, Celator Pharmaceuticals, Editas Medicine, Ignyta, Inspiremd Ord, Ldr Hldg, Lantheus Holdings Inc Common Stock Usd 0.01. LLY, NVS, RAD, SGMO, Sarepta Therapeutics, Scynexis, SHPGY, UTHR, Vitamin Shoppe, Jazz Pharmaceuticals.
- As of June 30, 2016, Sio Capital Management has $195.76M in assets under management (AUM). Assets under management dropped from a total value of $273.23M to $195.76M.
- Independent of market fluctuations, Sio Capital Management was a net seller by $70.20M worth of stocks in the most recent quarter.
Sio Capital Management portfolio companies for June 2016 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Quotient Ltd shs | 9.24 | 2.33M | 7.75 | 0.00 |
| Biogen Idec (BIIB) | 7.54 | 61000 NEW | 241.82 | 415.20 |
| Cerner Corporation (CERN) | 6.88 | 230000 NEW | 58.60 | 69.83 |
| Cardinal Health (CAH) | 6.79 | 170404 +26.00% | 78.01 | 87.33 |
| Amgen (AMGN) | 5.91 | 76000 -2.00% | 152.14 | 153.92 |
| athenahealth (ATHN) | 5.86 | 83100 +731.00% | 138.01 | 120.44 |
| Koninklijke Philips Electronics NV (PHG) | 4.39 | 344207 +22.00% | 24.94 | 28.08 |
| Sanofi-Aventis SA (SNY) | 4.28 | 200000 -2.00% | 41.85 | 47.19 |
| Neos Therapeutics | 4.02 | 847127 -34.00% | 9.28 | 0.00 |
| Anthera Pharmaceutcls | 4.00 | 2.54M -17.00% | 3.09 | 0.00 |
| Abbott Laboratories (ABT) | 3.51 | 174550 NEW | 39.31 | 46.40 |
| Johnson & Johnson (JNJ) | 3.41 | 55000 -45.00% | 121.31 | 98.55 |
| Medtronic | 3.32 | 75000 NEW | 86.77 | 0.00 |
| Pfizer (PFE) | 3.24 | 180000 NEW | 35.21 | 33.78 |
| Hill-Rom Holdings (HRC) | 2.15 | 83600 NEW | 50.45 | 47.72 |
| Tesaro | 2.15 | 50000 NEW | 84.06 | 0.00 |
| Novo Nordisk A/S (NVO) | 1.92 | 70000 NEW | 53.79 | 46.07 |
| Ecolab (ECL) | 1.82 | 30000 NEW | 118.60 | 115.32 |
| Celgene Corporation (CELG) | 1.76 | 35000 NEW | 98.63 | 118.26 |
| Rigel Pharmaceuticals (RIGL) | 1.52 | 1.33M -17.00% | 2.23 | 3.52 |
| Chemocentryx | 1.47 | 642828 NEW | 4.49 | 0.00 |
| Advanced Accelerat spon ads each rep 2 ord shs | 1.45 | 94177 -45.00% | 30.23 | 0.00 |
| Bristol Myers Squibb (BMY) | 1.41 | 37419 NEW | 73.55 | 66.08 |
| Ascendis Pharma A S | 1.37 | 202520 +8.00% | 13.27 | 0.00 |
| Foamix Pharmaceuticals Ltd shs | 1.31 | 405374 -29.00% | 6.35 | 0.00 |
| Trinet | 1.30 | 122563 -60.00% | 20.79 | 0.00 |
| Forward Pharma A/s | 1.16 | 124475 -42.00% | 18.17 | 0.00 |
| Adamis Pharmaceuticals Corp Com Stk | 0.98 | 684431 -45.00% | 2.80 | 0.00 |
| McKesson Corporation (MCK) | 0.95 | 10000 -88.00% | 186.70 | 221.98 |
| Quintiles Transnatio Hldgs I | 0.95 | 28541 NEW | 65.31 | 0.00 |
| Sage Therapeutics | 0.87 | 56800 NEW | 30.12 | 0.00 |
| Almost Family (AFAM) | 0.62 | 28452 NEW | 42.60 | 37.31 |
| Threshold Pharmaceuticals (THLD) | 0.44 | 1.33M -66.00% | 0.64 | 4.46 |
| Adamas Pharmaceuticals | 0.44 | 56500 +182.00% | 15.13 | 0.00 |
| Viking Therapeutics | 0.36 | 554382 NEW | 1.26 | 0.00 |
| Aeglea Biotherapeutics | 0.35 | 141874 NEW | 4.86 | 0.00 |
| Oasmia Pharmaceutical Ab | 0.22 | 123000 | 3.45 | 0.00 |
| Tearlab | 0.21 | 635442 NEW | 0.64 | 0.00 |
| Pfenex | 0.21 | 49092 -92.00% | 8.37 | 0.00 |
| Aratana Therapeutics | 0.19 | 59869 NEW | 6.31 | 0.00 |
| Immune Pharmaceuticals | 0.04 | 197655 | 0.40 | 0.00 |
Download CSV 
Past 13F-HR SEC Filings for Sio Capital Management
- Sio Capital Management 2016 Q1 filed May 16, 2016
- Sio Capital Management 2015 Q4 filed Feb. 16, 2016
- Sio Capital Management 2015 Q3 filed Nov. 13, 2015
- Sio Capital Management 2015 Q1 filed May 15, 2015
- Sio Capital Management 2014 Q4 filed Feb. 17, 2015
- Sio Capital Management 2011 Q1 filed May 17, 2011
- Sio Capital Management 2010 Q4 filed Feb. 8, 2011